The title compound, C 17 H 19 F 2 N 2 + ÁC 7 H 5 O 3 À ÁC 7 H 6 O 3 , is a cocrystal from 4-[bis(4-fluorophenyl)methyl]piperazin-1-ium, salicylate anion and salicylic acid in a 1:1:1 ratio. In addition to an intramolecular O-HÁ Á ÁO hydrogen bond, the crystal packing shows hydrogen bonds between the piperazinium cation and salicylate anion (N-HÁ Á ÁO), as well as between the salicylic acid molecule and anion (O-HÁ Á ÁO), giving rise to a three-dimensional network.
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Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). phenyl)methyl]piperazin-1-ium 2-(2-phenylethyl) benzoate (Betz et al., 2011a) , 4-[bis(4-fluorophenyl)methyl]-piperazin-1-ium picrate (Betz et al., 2011b) and cyclobenzaprinium salicylate (Fun et al., 2011) have been reported. In the course of our studies on the salts of piperazines and in view of the importance of piperazines, we now report the crystal and molecular structure of the title compound. The molecular structure of the cation is well known from ABADAK (Betz et al., 2011a) and AZOTOZ (Betz et al., 2011b) . The packing is stabilized from intermolecular N2-H2C···O22(-x + 0.5, y + 0.5, -z + 1.5), N2-H2D···O21, O12-H···O22 interactions, intra-molecular H bonds are O13-H···O11 (salicylic acid) and O23-H···O21 (anion). Molecular structure with displacement ellipsoids drawn at the 50% probability level.
4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium 2-hydroxybenzoate 2-hydroxybenzoic acid monosolvate
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